Digital biomarkers could fundamentally change MS care: A study shows that wearables and smartphone tests reliably map disability (EDSS) and fatigue (FSMC) in everyday life. Motor performance data and heart rate variability allow progression to be detected earlier and could make treatment decisions much more precise in future.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Digital biomarkers
Continuous monitoring using digital biomarkers in MS care
- Benefits, limits and safety aspects
Phytotherapy for cardiovascular diseases
- Results of the FOREST HCM study
Symptomatic obstructive hypertrophic cardiomyopathy
- Neuroprotection, resilience and cognitive health in old age
Longevity & Brain
- Obesity as a chronic disease: an interdisciplinary perspective
Neurobiological mechanisms of obesity
- Oncolytic virus in stage II melanoma
Innovative method for predicting therapy response
- Phimosis and penile cancer under SGLT2i
Increased risk for men with T2D
- Diabetic ketoacidosis